237 related articles for article (PubMed ID: 14733913)
21. Synergy between deacetylase inhibitors and IL-1beta in activation of the serum amyloid A2 gene promoter.
Blais M; Désilets A; Asselin C
DNA Cell Biol; 2005 Apr; 24(4):209-17. PubMed ID: 15812237
[TBL] [Abstract][Full Text] [Related]
22. Amyloidogenesis. One serum amyloid A isotype is selectively removed from the circulation.
Meek RL; Hoffman JS; Benditt EP
J Exp Med; 1986 Mar; 163(3):499-510. PubMed ID: 3950541
[TBL] [Abstract][Full Text] [Related]
23. Adrenoceptor-stimulated inflammatory response in stress-induced serum amyloid A synthesis.
Konstandi M; Sotiropoulos I; Matsubara T; Malliou F; Katsogridaki A; Andriopoulou CE; Gonzalez FJ
Psychopharmacology (Berl); 2019 Jun; 236(6):1687-1699. PubMed ID: 30612190
[TBL] [Abstract][Full Text] [Related]
24. Serum amyloid A transcription in Atlantic salmon (Salmo salar L.) hepatocytes is enhanced by stimulation with macrophage factors, recombinant human IL-1 beta, IL-6 and TNF alpha or bacterial lipopolysaccharide.
Jørgensen JB; Lunde H; Jensen L; Whitehead AS; Robertsen B
Dev Comp Immunol; 2000; 24(6-7):553-63. PubMed ID: 10831790
[TBL] [Abstract][Full Text] [Related]
25. Activation of Sp1 and its functional co-operation with serum amyloid A-activating sequence binding factor in synoviocyte cells trigger synergistic action of interleukin-1 and interleukin-6 in serum amyloid A gene expression.
Ray A; Schatten H; Ray BK
J Biol Chem; 1999 Feb; 274(7):4300-8. PubMed ID: 9933631
[TBL] [Abstract][Full Text] [Related]
26. Expression of serum amyloid A genes in mouse brain: unprecedented response to inflammatory mediators.
Tucker PC; Sack GH
FASEB J; 2001 Oct; 15(12):2241-6. PubMed ID: 11641251
[TBL] [Abstract][Full Text] [Related]
27. The kinetics and magnitude of the synergistic activation of the serum amyloid A promoter by IL-1 beta and IL-6 is determined by the order of cytokine addition.
Uhlar CM; Whitehead AS
Scand J Immunol; 1999 Apr; 49(4):399-404. PubMed ID: 10219766
[TBL] [Abstract][Full Text] [Related]
28. Serum amyloid A3 (SAA3), not SAA1 appears to be the major acute phase SAA isoform in the pig.
Soler L; Luyten T; Stinckens A; Buys N; Cerón JJ; Niewold TA
Vet Immunol Immunopathol; 2011 May; 141(1-2):109-15. PubMed ID: 21439655
[TBL] [Abstract][Full Text] [Related]
29. Synergistic activation of serum amyloid A (SAA) by IL-6 and IL-1 in combination on human Hep 3B hepatoma cell line. Role of PGE2 and IL-1 receptor antagonist.
Conti P; Bartle L; Barbacane RC; Reale M; Placido FC; Sipe J
Immunol Invest; 1995 Mar; 24(3):523-35. PubMed ID: 7790046
[TBL] [Abstract][Full Text] [Related]
30. The sphingomyelin-ceramide pathway participates in cytokine regulation of C-reactive protein and serum amyloid A, but not alpha-fibrinogen.
Lozanski G; Berthier F; Kushner I
Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):271-5. PubMed ID: 9359864
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of the major circulating precursors of proteins deposited in secondary amyloidosis by a recombinant mouse interleukin-1 receptor antagonist.
Grehan S; Herbert J; Whitehead AS
Eur J Immunol; 1997 Oct; 27(10):2593-9. PubMed ID: 9368615
[TBL] [Abstract][Full Text] [Related]
32. Human SAA1-derived amyloid deposition in cell culture: a consistent model utilizing human peripheral blood mononuclear cells and serum-free medium.
Ishii W; Liepnieks JJ; Yamada T; Benson MD; Kluve-Beckerman B
Amyloid; 2013 Jun; 20(2):61-71. PubMed ID: 23461622
[TBL] [Abstract][Full Text] [Related]
33. Amyloid formation in the rat: adenoviral expression of mouse serum amyloid A proteins.
Yu J; Guo JT; Zhu H; Kindy MS
Amyloid; 2000 Mar; 7(1):32-40. PubMed ID: 10842703
[TBL] [Abstract][Full Text] [Related]
34. Induction of serum amyloid A genes is associated with growth and apoptosis of HC11 mammary epithelial cells.
Kho Y; Kim S; Yoon BS; Moon JH; Kim B; Kwak S; Woo J; Oh S; Hong K; Kim S; Kim H; You S; Choi Y
Biosci Biotechnol Biochem; 2008 Jan; 72(1):70-81. PubMed ID: 18175929
[TBL] [Abstract][Full Text] [Related]
35. An active metabolite of leflunomide, A77 1726, inhibits the production of serum amyloid A protein in human hepatocytes.
Migita K; Miyashita T; Maeda Y; Nakamura M; Yatsuhashi H; Ishibashi H; Eguchi K
Rheumatology (Oxford); 2005 Apr; 44(4):443-8. PubMed ID: 15695308
[TBL] [Abstract][Full Text] [Related]
36. Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1.
Liepnieks JJ; Kluve-Beckerman B; Benson MD
Biochim Biophys Acta; 1995 Jan; 1270(1):81-6. PubMed ID: 7827140
[TBL] [Abstract][Full Text] [Related]
37. Expression of SAA1, SAA2 and SAA4 genes in human primary monocytes and monocyte-derived macrophages.
Jumeau C; Awad F; Assrawi E; Cobret L; Duquesnoy P; Giurgea I; Valeyre D; Grateau G; Amselem S; Bernaudin JF; Karabina SA
PLoS One; 2019; 14(5):e0217005. PubMed ID: 31100086
[TBL] [Abstract][Full Text] [Related]
38. STAT3 induces anti-hepatitis C viral activity in liver cells.
Zhu H; Shang X; Terada N; Liu C
Biochem Biophys Res Commun; 2004 Nov; 324(2):518-28. PubMed ID: 15474458
[TBL] [Abstract][Full Text] [Related]
39. Effect of amino acid variations in the central region of human serum amyloid A on the amyloidogenic properties.
Takase H; Tanaka M; Miyagawa S; Yamada T; Mukai T
Biochem Biophys Res Commun; 2014 Jan; 444(1):92-7. PubMed ID: 24440699
[TBL] [Abstract][Full Text] [Related]
40. A novel allelic variant of serum amyloid A, SAA1 gamma: genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA-amyloidosis.
Baba S; Masago SA; Takahashi T; Kasama T; Sugimura H; Tsugane S; Tsutsui Y; Shirasawa H
Hum Mol Genet; 1995 Jun; 4(6):1083-7. PubMed ID: 7655463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
